The Trump administration proposed curbing billions of dollars in annual rebates that drugmakers give middlemen in Medicare and some Medicaid plans, a practice it has blamed for inflated prescription prices.
from WSJ.com: US Business https://on.wsj.com/2MKT5Zm
via IFTTT
No comments:
Post a Comment